News

Medical Device Network on MSN5d
FDA approves Abbott’s TMVR system to treat mitral valve disease
The system is available for patients whose mitral valves are not working properly due to severe mitral annular calcification.
Healio5d
FDA approves transcatheter mitral valve replacement system for high surgical risk patients
Abbott announced the FDA approved its transcatheter mitral valve replacement system for patients with severe mitral annular ...
MassDevice6d
FDA approves Abbott mitral valve replacement device that doesn’t require open-heart surgery
Abbott (NYSE: ABT) announced today that it received FDA approval for its Tendyne transcatheter mitral valve replacement (TMVR ...
Fierce Biotech6d
Abbott snags US approval for Tendyne mitral valve replacement implant
The FDA approved Abbott's Tendyne minimally invasive heart replacement for mitral valve disease that could disqualify ...
Crain's Chicago Business6d
Abbott wins approval for open-heart surgery-free valve replacement
The FDA gave the OK for the North Chicago-based medical device maker's Tendyne transcatheter mitral valve replacement.
Pharmabiz4d
US FDA approves Abbott’s Tendyne, first-of-its-kind device to replace the mitral valve without open-heart surgery
US FDA approves Abbott’s Tendyne, first-of-its-kind device to replace the mitral valve without open-heart surgery: Abbott Park, Illinois Thursday, May 29, 2025, 16:00 Hrs [IST] ...
Nagpur Today3d
Central India’s First Total Endoscopic Mitral Valve Replacement Performed at Shalinitai Meghe Hospital,
In a groundbreaking development for cardiac care in Central India, Shalinitai Meghe Hospital and Research Centre (SMHRC), - ...
Abbott wins FDA approval for mitral valve replacement device, teeing up Edwards competition
Abbott said the Tendyne system addresses a significant unmet need in cardiac care, providing an option for patients ineligible for open heart surgery and whose valves cannot be successfully repaired ...
Medical Dialogues3d
FDA Approves Abbott's Tendyne TMVR System for Mitral Valve Disease
The US Food and Drug Administration has approved Abbott's Tendyne Transcatheter Mitral Valve Replacement (TMVR) system. It is indicated for patients with mitral valve disease caused by ...
Abbott Receives FDA Approval for Tendyne™, First-of-Its-Kind Device to Replace the Mitral Valve Without Open-Heart Surgery
Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved the company's Tendyne™ transcatheter mitral valve replacement (TMVR) system to treat people with mitral ...